Geode Capital Management, LLC Outlook Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.22 - $0.66 $41,110 - $123,330	186,865 Added 6.71%	2,970,346 $1.16 Million
Q3 2023 Nov 13, 2023	BUY	$0.2 - $1.78 $12,537 - $111,581	62,686 Added 2.3%	2,783,481 $612,000
Q2 2023 Aug 11, 2023	BUY	$1.02 - $1.89 $186,782 - $346,096	183,120 Added 7.22%	2,720,795 $4.73 Million
Q1 2023 May 15, 2023	BUY	$1.0 - $1.35 $475,477 - $641,893	475,477 Added 23.06%	2,537,675 $2.77 Million
Q4 2022 Feb 13, 2023	SELL	$0.87 - $1.33 $1,305 - $1,996	-1,501 Reduced 0.07%	2,062,198 $2.23 Million
Q3 2022 Nov 14, 2022	BUY	$1.02 - $1.26 $6,007 - $7,421	5,890 Added 0.29%	2,063,699 $2.52 Million
Q2 2022 Aug 12, 2022	BUY	$0.91 - $2.01 $175,815 - $388,340	193,204 Added 10.36%	2,057,809 $2.1 Million
Q1 2022 May 13, 2022	BUY	$1.22 - $2.03 $403,552 - $671,485	330,781 Added 21.57%	1,864,605 $3.32 Million
Q4 2021 Feb 11, 2022	SELL	$1.27 - $2.23 $23,639 - $41,509	-18,614 Reduced 1.2%	1,533,824 $2.09 Million
Q3 2021 Nov 12, 2021	BUY	$2.12 - $2.76 $77,064 - $100,328	36,351 Added 2.4%	1,552,438 $3.37 Million
Q2 2021 Aug 13, 2021	BUY	$1.78 - $2.76 $1.38 Million - $2.14 Million	774,405 Added 104.41%	1,516,087 $3.78 Million
Q1 2021 May 12, 2021	BUY	$0.94 - $3.31 $444,668 - $1.57 Million	473,052 Added 176.1%	741,682 $1.67 Million
Q4 2020 Feb 12, 2021	BUY	$0.7 - $1.58 $43,785 - $98,830	62,551 Added 30.35%	268,630 $349,000
Q3 2020 Nov 13, 2020	BUY	$0.61 - $1.6 $52,818 - $138,540	86,588 Added 72.46%	206,079 $148,000
Q2 2020 Aug 13, 2020	BUY	$0.56 - $1.41 $29,262 - $73,678	52,254 Added 77.72%	119,491 $154,000
Q3 2019 Nov 12, 2019	BUY	$1.32 - $2.63 $45,879 - $91,410	34,757 Added 107.01%	67,237 $100,000
Q2 2019 Aug 14, 2019	BUY	$0.91 - $7.68 $29,556 - $249,446	32,480 New	32,480 $67,000

Others Institutions Holding OTLK

# of Institutions

Shares Held

31.5K

Call Options Held

Put Options Held

View Full List

About Outlook Therapeutics, Inc.

Ticker OTLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,144,992
Market Cap $317M
Description
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...

More about OTLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account